ADDF – Preclinical Drug Discovery RFP 2017
Objetivo: The ADDF offers funding to researchers in both nonprofit and for-profit organizations for Alzheimer’s drug discovery and preclinical development, clinical trials, and biomarker development research.
Inscrições: até 17 de novembro de 2017
Mais informações no site.